世界のスポーツ医療市場分析及び予測...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 8
1.1 List of Tables 15
1.2 List of Figures 21
2 Introduction 23
2.1 Catalyst 24
2.2 Related Reports 26
2.3 Upcoming Related Reports 26
3 Clinical Outcomes 27
3.1 Conservative Treatments 27
3.1.1 Immobilization and Bracing 28
3.1.2 Physical Therapy 28
3.1.3 Muscle Stimulation 29
3.2 Drug Therapy 29
3.2.1 Nutritional Supplements 30
3.2.2 Analgesics and NSAIDs 30
3.2.3 Corticosteroids 30
3.2.4 Viscosupplementation 30
3.3 Soft Tissue Repair 31
3.4 Arthroscopy 33
3.5 Plates and Screws 34
3.6 Joint Replacement 35
4 Industry Overview 36
4.1 Overview 36
4.2 Procedure Trends 37
4.2.1 US 37
4.2.2 EU 39
4.2.3 Asia-Pacific Region 41
4.2.4 South America 42
4.3 Market Access 43
4.3.1 US 43
4.3.2 EU 48
4.3.3 Asia-Pacific Region 56
4.3.4 South America 63
4.4 Disputes and Settlements 66
4.4.1 Smith & Nephew Granted an Injunction Against Arthrex 66
4.4.2 KFx Medical and Smith & Nephew Enter Into Licensing Agreement 66
4.4.3 KFx Medical Wins Patent Infringement Lawsuit Against Arthrex 67
4.4.4 ArthroCare and Smith & Nephew Settle Legal Disputes 67
4.5 Mergers, Acquisitions, Partnerships, and Other Deals 67
4.5.1 Stryker Acquires Pivot Medical 67
4.5.2 Smith & Nephew Announces Acquisition of ArthroCare 67
4.5.3 Smith & Nephew Acquires Plato Grup Assets 68
4.5.4 Smith & Nephew Announces Acquisition of Its Brazil Distribution Business 68
4.5.5 Kensey Nash Acquires Minority Stake in Orteq Sports Medicine 68
4.5.6 Tornier Acquires C2M Medical 68
4.5.7 Tornier Signs Licensing Agreement with T.A.G. Medical Products Corporation 68
4.5.8 Biomet Acquires Cartilix 69
4.5.9 Biomet Sports Medicine Enters Into Deal With Marc Tec 69
4.6 Economic Impact 69
4.6.1 Developed Countries 69
4.6.2 Emerging Markets 71
5 Unmet Needs 73
5.1 Long-Term Clinical Data 73
5.1.1 Hip Arthroscopic Implants Clinical Data 73
5.1.2 Rotator Cuff Injury Clinical Data 73
5.2 Cartilage and Meniscal Repair Product Development 74
5.2.1 Knee Meniscus Treatment 74
5.2.2 Hip Cartilage Product Development 76
5.3 Biologics for Faster Healing 77
5.4 Standardization and Improvement of Instruments 78
5.4.1 Hip and Shoulder Instrumentation 78
5.4.2 Screwdriver Standardization 78
5.5 Fellowship Training Programs 79
5.6 Advanced Materials Research 80
5.7 Bioabsorbable Technology Development 81
5.8 Centralization 83
5.9 Need for Cost-Containment 83
5.10 Suture Anchor Product Development 84
6 Market Opportunity Analysis 86
6.1 Adding More Training Programs 86
6.2 Product Line Extensions 86
6.3 Lack of Pricing Pressure in Sports Medicine 87
6.4 Mergers and Acquisitions 88
6.5 Seasonality of Sports Medicine 89
6.6 Emerging Markets 89
6.7 Minimally-Invasive Surgical Preference 90
7 Market Drivers, Barriers and Substitutes 91
7.1 Driver: Rising Prevalence 91
7.1.1 Sports-Related Injuries 91
7.1.2 Aging 91
7.1.3 Trauma 92
7.2 Driver: Hip Arthroscopy 93
7.2.1 Femoroacetabular Impingement Growth 94
7.2.2 Hip Arthroscopy Fellowship Training Programs 95
7.3 Driver: Knee and Shoulder Arthroscopy 95
7.4 Driver: Revision Surgery 96
7.5 Driver: Patient Demand and Awareness 97
7.6 Driver: Orthobiologics Development 98
7.6.1 Bone Grafts 98
7.6.2 Platelet-Rich Plasma 99
7.7 Driver: Rising Competition and Innovation Through Small Players 99
7.8 Driver: Materials Development 99
7.8.1 Composite Materials and Biopolymers 100
7.8.2 Bioabsorbables 100
7.8.3 Metallic Alloys in Orthopedics 101
7.9 Barrier: Arthroscopy’s Questionable Outcomes 102
7.9.1 Hip Arthroscopy 102
7.9.2 Knee Arthroscopy 103
7.10 Barrier: Steep Learning Curve 104
7.11 Barrier: Reimbursement 104
7.12 Barrier: Burden of Rising Regulation 106
7.13 Barrier: Proving Efficacy 107
7.14 Barrier: Medical Device Excise Tax 108
7.15 Substitute: Open Surgery Versus Minimally-Invasive Arthroscopy 108
7.16 Substitute: Conservative Treatment Options 109
8 Competitive Assessment 110
8.1 Overview 110
8.2 Marketed Products in Sports Medicine 110
8.2.1 Arthrex 110
8.2.2 ArthroCare Corporation 117
8.2.3 Biomet 121
8.2.4 ConMed Corporation 125
8.2.5 DePuy Mitek 130
8.2.6 Smith & Nephew 134
8.2.7 Stryker 136
8.2.8 Tornier 139
9 Pipeline Assessment 140
9.1 Overview 140
9.2 Product Profiles 140
9.2.1 Bioretec Drug-Releasing Screws 140
9.2.2 Nanova Bioabsorbable Bone Screws 140
9.2.3 MinInvasive Arthroscopic Suture Passer 140
9.2.4 SpineSmith Pipeline 141
9.2.5 DePuy Mitek FMS VUE 141
9.2.6 Pivot Medical Hip Arthroscopy System 141
9.2.7 University of Florida Shoulder Labral Anchor Delivery System 141
9.2.8 University of California at San Diego Cartilage Regeneration Device 141
10 Clinical Trials to Watch 142
10.1 Overview 142
10.2 Can Shoulder Arthroscopy Work (CSAW) Study 142
10.3 Arthroscopy in the Treatment of Degenerative Medial Meniscus Tear 142
10.4 Knee Arthroscopy Cohort Southern Denmark 143
10.5 Hip Arthroscopy Versus Conservative Management of Femoroacetabular Impingement 143
10.6 Femoroacetabular Impingement Randomized Controlled Trial 144
10.7 Multicenter ACL Revision Study (MARS) 144
10.8 Arthroscopic Versus Open Stabilization for Traumatic Shoulder Instability 145
10.9 Microfracture in the Knee Study 145
10.10 Single- Versus Double-Row Suture Anchor Repair in Medium to Large Rotator Cuff Tears 146
10.11 Early Surgery Versus Conservative Therapy for Meniscal Injuries in Older Patients (ESCAPE) 146
10.12 Arthroscopic Rotator Cuff Repair of Full Thickness Tears With and Without Arthroscopic Acromioplasty 147
10.13 Arthroscopic Rotator Cuff Repair With Platelet-Rich Plasma 148
10.14 Tibial Tunnel Widening in ACL Reconstruction-Comparing Two Bioscrews 148
11 Current and Future Players 149
11.1 Trends in Corporate Strategy 149
11.2 Company Profiles 150
11.2.1 Arthrex 150
11.2.2 ArthroCare Corporation 152
11.2.3 Biomet 154
11.2.4 ConMed Corporation 157
11.2.5 DePuy Companies 159
11.2.6 Smith & Nephew 161
11.2.7 Stryker 163
11.2.8 Tornier 165
11.2.9 Wright Medical Group 168
11.2.10 Other Key Players in Sports Medicine 171
12 Market Outlook 177
12.1 Company Market Share 177
12.1.1 Overview 177
12.1.2 US 177
12.1.3 EU Market Share 178
12.1.4 Asia-Pacific Market Share 181
12.1.5 South America Market Share 183
12.2 By Market Segment 184
12.2.1 Overview 184
12.2.2 Arthroscopy Implants 185
12.2.3 Arthroscopic Shavers 186
12.2.4 Arthroscopes 187
12.2.5 Arthroscopic Radio Frequency Wands 188
12.2.6 Arthroscopic Visualization Systems 189
12.2.7 Arthroscopic Fluid Management Systems 190
12.3 By Geography 192
12.3.1 Global Overview 192
12.3.2 US 195
12.3.3 EU 198
12.3.4 Asia-Pacific 209
12.3.5 South America 215
13 Appendix 218
13.1 Bibliography 218
13.2 Abbreviations 228
13.3 Research Methodology 233
13.3.1 Overview 233
13.3.2 Coverage 233
13.3.3 Secondary Research 233
13.4 Physicians and Specialists Included in this Study 235
13.4.1 Dr. Henry D.E. Atkinson 235
13.4.2 Dr. Joshua Alpert 235
13.4.3 Dr. Andrea Ferretti 235
13.4.4 Dr. Alejandro Gonzalez Della Valle 235
13.4.5 Dr. Andreas Imhoff 235
13.4.6 Dr. Marcello Zaia Oliveira 235
13.4.7 Dr. Vidhya Ravi 236
13.4.8 Dr. Elvire Servien 236
13.4.9 Dr. Yotaro Yamakado 236
13.5 Primary Research 237
13.5.1 Primary Research – Key Opinion Leader Interviews 237
13.5.2 Primary Research – Physician and Industry Interviews 237
13.5.3 Expert Panel Validation 238
13.6 Forecasting Methodology 238
13.7 About the Authors 240
13.7.1 Analysts 240
13.7.2 Global Head of Healthcare 241
13.8 About MediPoint 242
13.9 About GlobalData 242
13.10 Disclaimer 242